Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

The impact of SLCO1B1 genetic polymorphisms on neonatal hyperbilirubinemia: a systematic review with meta-analysis.

Liu J, Long J, Zhang S, Fang X, Luo Y.

J Pediatr (Rio J). 2013 Sep-Oct;89(5):434-43. doi: 10.1016/j.jped.2013.01.008. Epub 2013 Jul 11. Review.

2.

Polymorphic variants of SLCO1B1 in neonatal hyperbilirubinemia in China.

Liu J, Long J, Zhang S, Fang X, Luo Y.

Ital J Pediatr. 2013 Aug 12;39:49. doi: 10.1186/1824-7288-39-49.

3.

Genetic polymorphisms in Thai neonates with hyperbilirubinemia.

Prachukthum S, Nunnarumit P, Pienvichit P, Chuansumrit A, Songdej D, Kajanachumpol S, Pakakasama S, Hongeng S.

Acta Paediatr. 2009 Jul;98(7):1106-10. doi: 10.1111/j.1651-2227.2009.01275.x. Epub 2009 Apr 21.

PMID:
19397531
4.

[OATP 1B1 T521C/A388G is an important polymorphism gene related to neonatal hyperbilirubinemia].

Zhang HX, Zhao X, Yang Z, Peng CY, Long R, Li GN, Li J, He ZK.

Zhonghua Er Ke Za Zhi. 2010 Sep;48(9):650-5. Chinese.

PMID:
21092521
5.

Multiple Genetic Modifiers of Bilirubin Metabolism Involvement in Significant Neonatal Hyperbilirubinemia in Patients of Chinese Descent.

Yang H, Wang Q, Zheng L, Lin M, Zheng XB, Lin F, Yang LY.

PLoS One. 2015 Jul 6;10(7):e0132034. doi: 10.1371/journal.pone.0132034. eCollection 2015.

6.

Complex multifactorial nature of significant hyperbilirubinemia in neonates.

Watchko JF, Lin Z, Clark RH, Kelleher AS, Walker MW, Spitzer AR; Pediatrix Hyperbilirubinemia Study Group.

Pediatrics. 2009 Nov;124(5):e868-77. doi: 10.1542/peds.2009-0460. Epub 2009 Oct 26.

PMID:
19858149
7.

Risk factors associated with unconjugated neonatal hyperbilirubinemia in Malaysian neonates.

Wong F, Boo N, Othman A.

J Trop Pediatr. 2013 Aug;59(4):280-5. doi: 10.1093/tropej/fmt023. Epub 2013 May 2.

PMID:
23640907
8.

Association of neonatal hyperbilirubinemia in breast-fed infants with UGT1A1 or SLCOs polymorphisms.

Sato H, Uchida T, Toyota K, Nakamura T, Tamiya G, Kanno M, Hashimoto T, Watanabe M, Aoki K, Hayasaka K.

J Hum Genet. 2015 Jan;60(1):35-40. doi: 10.1038/jhg.2014.98. Epub 2014 Nov 13.

PMID:
25391605
9.

Exploring the genetic architecture of neonatal hyperbilirubinemia.

Watchko JF, Lin Z.

Semin Fetal Neonatal Med. 2010 Jun;15(3):169-75. doi: 10.1016/j.siny.2009.11.003. Epub 2009 Dec 21. Review.

PMID:
20022574
10.

UGT1A1, SLCO1B1, and SLCO1B3 polymorphisms vs. neonatal hyperbilirubinemia: is there an association?

Alencastro de Azevedo L, Reverbel da Silveira T, Carvalho CG, Martins de Castro S, Giugliani R, Matte U.

Pediatr Res. 2012 Aug;72(2):169-73.

PMID:
22580719
11.
12.

Pharmacogenetics of SLCO1B1: haplotypes, htSNPs and hepatic expression in three distinct Asian populations.

Jada SR, Xiaochen S, Yan LY, Xiaoqiang X, Lal S, Zhou SF, Ooi LL, Chowbay B.

Eur J Clin Pharmacol. 2007 Jun;63(6):555-63. Epub 2007 Apr 6. Erratum in: Eur J Clin Pharmacol. 2007 Aug;63(8):813-4.

PMID:
17415554
13.

Neonatal hyperbilirubinemia and Gly71Arg mutation of UGT1A1 gene: a Chinese case-control study followed by systematic review of existing evidence.

Long J, Zhang S, Fang X, Luo Y, Liu J.

Acta Paediatr. 2011 Jul;100(7):966-71. doi: 10.1111/j.1651-2227.2011.02176.x. Epub 2011 Feb 25. Review. Erratum in: Acta Paediatr. 2012 Nov;101(11):1184.

PMID:
21272068
14.

[Research progress on the relationship between SLCO1B1 gene and neonatal jaundice].

Lu AF, Zhong DN.

Zhongguo Dang Dai Er Ke Za Zhi. 2014 Nov;16(11):1183-7. Review. Chinese.

PMID:
25406570
15.

Association of neonatal hyperbilirubinemia with uridine diphosphate-glucuronosyltransferase 1A1 gene polymorphisms: meta-analysis.

Long J, Zhang S, Fang X, Luo Y, Liu J.

Pediatr Int. 2011 Aug;53(4):530-40. doi: 10.1111/j.1442-200X.2011.03337.x.

PMID:
21342357
16.

Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment.

Lee E, Ryan S, Birmingham B, Zalikowski J, March R, Ambrose H, Moore R, Lee C, Chen Y, Schneck D.

Clin Pharmacol Ther. 2005 Oct;78(4):330-41.

PMID:
16198652
17.

Effects of statin treatments and polymorphisms in UGT1A1 and SLCO1B1 on serum bilirubin levels in Chinese patients with hypercholesterolaemia.

Hu M, Tomlinson B.

Atherosclerosis. 2012 Aug;223(2):427-32. doi: 10.1016/j.atherosclerosis.2012.06.002. Epub 2012 Jun 13.

PMID:
22749334
18.

Duplex pyrosequencing assay of the 388A>G and 521T>C SLCO1B1 polymorphisms in three Asian populations.

Kim EY, Cho DY, Shin HJ, Lee SS, Shon JH, Shin JG, Shin SG.

Clin Chim Acta. 2008 Feb;388(1-2):68-72. Epub 2007 Oct 12.

PMID:
17996736
19.

Organic anion transporting polypeptide-1B1 haplotypes in Chinese patients.

Xu LY, He YJ, Zhang W, Deng S, Li Q, Zhang WX, Liu ZQ, Wang D, Huang YF, Zhou HH, Sun ZQ.

Acta Pharmacol Sin. 2007 Oct;28(10):1693-7.

20.

Influence of genomic ancestry on the distribution of SLCO1B1, SLCO1B3 and ABCB1 gene polymorphisms among Brazilians.

Sortica Vde A, Ojopi EB, Genro JP, Callegari-Jacques S, Ribeiro-Dos-Santos A, de Moraes MO, Romano-Silva MA, Pena SD, Suarez-Kurtz G, Hutz MH.

Basic Clin Pharmacol Toxicol. 2012 May;110(5):460-8. doi: 10.1111/j.1742-7843.2011.00838.x. Epub 2011 Dec 29.

Supplemental Content

Support Center